학술논문
Upadacitinib for moderate-to-severe atopic dermatitis: Stratified analysis from three randomized phase 3 trials by key baseline characteristics
Document Type
Article
Author
Source
In: Journal of the European Academy of Dermatology and Venereology . (Journal of the European Academy of Dermatology and Venereology, September 2023, 37(9):1871-1880)
Subject
Language
English
ISSN
14683083
09269959
09269959